Home > Insider Trading > Filing (0001209191-15-018753)

Filing Details

Accession Number:: 0001209191-15-018753
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-25 18:15:54
Reporting Period:: 2015-02-23

Filing Date:: 2015-02-25
Accepted Time:: 2015-02-25 18:15:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1281895	Inotek Pharmaceuticals Corp	ITEK	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
943431	Joshua Ruch	152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No
1082907	Habib Kairouz	152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No
1120545	Mark Leschly	152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No
1126016	Rho Ventures Iv Lp	152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No
1126022	Rho Ventures Iv Qp Lp	152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No
1269064	Rho Management Ventures Iv Llc	152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No
1269066	Rho Ventures Iv Gmbh & Co Beteiligungs Kg	152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No
1269068	Gmbh Verwaltungs Partners Capital Rho	152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No
1533275	Rho Ventures Iv Holdings Llc	C/O Rho Capital Partners, Inc. 152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No
1632862	Rho Ventures Iv-A, L.p.	152 West 57Th Street, 23Rd Floor New York NY 10019	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-23	1,606,230	$0.00	1,839,266	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2015-02-23	73,092	$0.00	1,912,358	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2015-02-23	958,226	$6.00	2,870,584	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series AA Convertible Preferred Stock	Disposition	2015-02-23	5,128,577	$0.00	1,606,230	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2015-02-23	432,591	$0.00	73,092	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Consists of the following shares of Common Stock issued upon conversion of shares of Series AA Convertible Preferred Stock ("Series AA") and accrued and unpaid dividends thereon, on a 4.05783-for-1 basis, upon the closing of the Issuer's initial public offering: (i) 473,479 shares held directly by Rho Ventures IV (QP), L.P. ("RV QP"), (ii) 493,435 shares held directly by Rho Ventures IV GmbH & Co. BETEILIGUNGS KG ("RV KG"), (iii) 438,202 shares held directly by Rho Ventures IV Holdings, LLC ("RV Holdings"), (iv) 89,584 shares held directly by Rho Ventures IV, L.P. ("RV IV") and (v) 111,530 shares held directly by Rho Ventures IV-A, L.P. ("RV IV-A"). The shares of Series AA had no expiration date.
Rho Management Ventures IV, L.L.C. ("RMV") is the general partner of RV IV, RV QP, RV Holdings, RV IV-A. Rho Capital Partners Verwaltungs GmbH ("RCP GmbH") is the general partner of RV KG. Each of RMV and RCP GmbH disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that such filer is the beneficial owner of such securities, except to the extent of its pecuniary interest therein. Habib Kairouz, Joshua Ruch and Mark Leschly are managing members of RMV and managing directors of RCP GmbH. Each of Habib Kairouz, Joshua Ruch and Mark Leschly disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of his pecuniary interest therein.
The outstanding principal amount and all accrued and unpaid interest under the Convertible Promissory Notes were automatically converted upon the closing of the Issuer's initial public offering into shares of Common Stock at the initial public offering price of $6.00 per share. The Convertible Promissory Notes had no expiration date. The number of shares of Common Stock as shown in column 4 of Table I consists of the following: (i) 24,823 shares held directly by RV QP, (ii) 25,869 shares held directly by RV KG, (iii) 17,704 shares held directly by RV Holdings and (iv) 4,696 shares held directly by RV IV.
Consists of the following shares purchased at the Issuer's initial public offering: (i) 325,420 shares held directly by RV QP, (ii) 339,135 shares held directly by RV KG, (iii) 232,098 shares held directly by RV Holdings and (iv) 61,573 shares held directly by RV IV.